Literature DB >> 20634089

High interleukin-12 production from stimulated peripheral blood mononuclear cells of type 2 diabetes patients.

Huang-Pin Wu1, Sheng-Fong Kuo, Shao-Yun Wu, Duen-Yau Chuang.   

Abstract

UNLABELLED: Sugar control is important in patients with sepsis. Interleukin (IL)-12 induces the polarization of CD4(+) T cells to the T helper 1 (Th1) phenotype. Regulatory T (T(reg)) cells are important in immunity and disease. The aim of this work is to determine whether hyperglycemia or insulin alters IL-12 response in peripheral mononuclear cells (PBMCs).
METHODS: The PBMCs from 15 type 2 diabetes mellitus (DM) patients and 13 healthy controls were used for cell analysis and culture with or without treatment by glucose and insulin or stimulation by lipopolysaccharide (LPS) for 1, 2, and 3 days.
RESULTS: The IL-12 level in the supernatant of LPS-stimulated PBMCs in the DM patients was significantly higher than that of healthy controls from day 1 to day 3. Kinetic IL-12 responses of LPS-stimulated PBMCs in the DM patients from day 1 to day 3 were significantly higher than that in healthy controls. The LPS-stimulated PBMCs under glucose treatment produced more IL-12 in DM patients but this did not happen in healthy controls. In DM patients, insulin could suppress IL-12 production from stimulated PBMCs but not with additional glucose treatment.
CONCLUSION: The PBMCs of LPS-treated DM patients produced more IL-12 than that of LPS-treated healthy controls did. Hyperglycemia influenced IL-12 response from PBMCs in DM patients to some degree during infection. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20634089     DOI: 10.1016/j.cyto.2010.06.014

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  4 in total

Review 1.  Resistance to type 2 diabetes mellitus: a matter of hormesis?

Authors:  Hubert Kolb; Décio L Eizirik
Journal:  Nat Rev Endocrinol       Date:  2011-10-25       Impact factor: 43.330

2.  Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trial.

Authors:  Yong Zhao; Zhaoshun Jiang; Tingbao Zhao; Mingliang Ye; Chengjin Hu; Huimin Zhou; Zhaohui Yin; Yana Chen; Ye Zhang; Shanfeng Wang; Jie Shen; Hatim Thaker; Summit Jain; Yunxiang Li; Yalin Diao; Yingjian Chen; Xiaoming Sun; Mary Beth Fisk; Heng Li
Journal:  BMC Med       Date:  2013-07-09       Impact factor: 8.775

3.  Elevated levels of serum IL-12 and IL-18 are associated with lower frequencies of CD4(+)CD25 (high)FOXP3 (+) regulatory t cells in young patients with type 1 diabetes.

Authors:  Monika Ryba-Stanisławowska; Karolina Rybarczyk-Kapturska; Małgorzata Myśliwiec; Jolanta Myśliwska
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

4.  Serum IL-12 is increased in Mexican obese subjects and associated with low-grade inflammation and obesity-related parameters.

Authors:  K Suárez-Álvarez; L Solís-Lozano; S Leon-Cabrera; A González-Chávez; G Gómez-Hernández; M S Quiñones-Álvarez; A E Serralde-Zúñiga; J Hernández-Ruiz; J Ramírez-Velásquez; F J Galindo-González; J C Zavala-Castillo; M A De León-Nava; G Robles-Díaz; G Escobedo
Journal:  Mediators Inflamm       Date:  2013-02-20       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.